Cargando…

Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection

The infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) generated many challenges to find an effective drug combination for hospitalized patients with severe forms of coronavirus disease 2019 (COVID-19) pneumonia. We conducted a retrospective cohort study, including 182 patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vulturar, Damiana-Maria, Neag, Maria Adriana, Vesa, Ștefan Cristian, Maierean, Anca-Diana, Gherman, Diana, Buzoianu, Anca Dana, Orăsan, Olga Hilda, Todea, Doina-Adina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698366/ https://www.ncbi.nlm.nih.gov/pubmed/36430945 http://dx.doi.org/10.3390/ijms232214462

Ejemplares similares

Gastrointestinal microbiota: A predictor of COVID-19 severity?
por: Neag, Maria Adriana, et al.
Publicado: (2022)

Obesity Impact on SARS-CoV-2 Infection: Pros and Cons “Obesity Paradox”—A Systematic Review
por: Vulturar, Damiana-Maria, et al.
Publicado: (2022)

The Management of Obstructive Sleep Apnea Patients during the COVID-19 Pandemic as a Public Health Problem—Interactions with Sleep Efficacy and Mental Health
por: Maierean, Anca Diana, et al.
Publicado: (2023)

Change in Neuroticism and Extraversion among Pre-University Education Employees during the COVID-19 Pandemic
por: Alexescu, Teodora-Gabriela, et al.
Publicado: (2022)

Multivariate Analysis of the Predicted Probability of Smoking Behavior of Foster Care Minors: Results of a Study from Romania
por: Budin, Corina Eugenia, et al.
Publicado: (2022)

A Prospective Study of CPAP Therapy in Relation to Cardiovascular Outcome in a Cohort of Romanian Obstructive Sleep Apnea Patients
por: Chetan, Ioana Maria, et al.
Publicado: (2021)

Polymorphism of the Serotonin Transporter Gene and the Peripheral 5-Hydroxytryptamine in Obstructive Sleep Apnea: What Do We Know and What are We Looking for? A Systematic Review of the Literature
por: Maierean, Anca Diana, et al.
Publicado: (2021)

Remdesivir/tocilizumab: Endogenous endophthalmitis: 3 case reports
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Various toxicities: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy: case report
Publicado: (2022)

Short-Chain Fatty Acids as Bacterial Enterocytes and Therapeutic Target in Diabetes Mellitus Type 2
por: Neag, Maria-Adriana, et al.
Publicado: (2022)

IL-6 and Neutrophil/Lymphocyte Ratio as Markers of ICU Admittance in SARS-CoV-2 Patients with Diabetes
por: Făgărășan, Iulia, et al.
Publicado: (2023)

Remdesivir vs tocilizumab in COVID-19: adverse event profiles
Publicado: (2021)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Predictors of New-Onset Diabetes in Hospitalized Patients with SARS-CoV-2 Infection
por: Făgărășan, Iulia, et al.
Publicado: (2022)

The role of 3D speckle tracking echocardiography in the diagnosis of obstructive sleep apnea and its severity
por: Chetan, Ioana Maria, et al.
Publicado: (2022)

Gut Molecules in Cardiometabolic Diseases: The Mechanisms behind the Story
por: Inceu, Andreea-Ioana, et al.
Publicado: (2023)

Influence of concomitant medication on plasma concentration of amiodarone in patients with atrial fibrillation - a pilot study
por: Neag, Maria Adriana, et al.
Publicado: (2019)

Remdesivir/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Methaemoglobinaemia and off-label use: case report
Publicado: (2021)

Remdesivir
por: Bakheit, Ahmed H., et al.
Publicado: (2023)

Overview of the microbiota in the gut-liver axis in viral B and C hepatitis
por: Neag, Maria Adriana, et al.
Publicado: (2021)

Remdesivir/tocilizumab: Drug ineffective and off-label use: 2 case reports
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy and off label use: case report
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Off-label use and lack of efficacy: case report
Publicado: (2022)

The Use of Single Therapy With Tocilizumab Versus Combination Therapy With Remdesivir and Tocilizumab in SARS-CoV-2 Patients in El Paso, Texas
por: Almaghlouth, Nouf K, et al.
Publicado: (2021)

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
por: Rosas, Ivan O., et al.
Publicado: (2021)

Remdesivir in Breastfeeding
por: Sadati, Elham, et al.
Publicado: (2022)

Bacillus spp. Spores—A Promising Treatment Option for Patients with Irritable Bowel Syndrome
por: Catinean, Adrian, et al.
Publicado: (2019)

The Protective Effects of Nutraceutical Components in Methotrexate-Induced Toxicity Models—An Overview
por: Marin, Gheorghe-Eduard, et al.
Publicado: (2022)

An overview on the interplay between nutraceuticals and gut microbiota
por: Catinean, Adrian, et al.
Publicado: (2018)

Remdesivir/tocilizumab: Rebound of HCV viral load and loss of anti-HBs: case report
Publicado: (2021)

551. Remdesivir and Tocilizumab for the Treatment of Severe COVID-19 in a Community Hospital: A Retrospective Cohort Study
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

Remdesivir: Infusion site reaction following extravasation of remdesivir: case report
Publicado: (2021)

Successful management of remdesivir extravasation
por: Conde-Estévez, David, et al.
Publicado: (2022)

Characterization of Patients with Allergic Rhinitis to Ragweed Pollen in Two Distinct Regions of Romania
por: Bocsan, Ioana Corina, et al.
Publicado: (2019)

Remdesivir: First Approval
por: Lamb, Yvette N.
Publicado: (2020)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

Remdesivir for COVID-19
Publicado: (2020)

Remdesivir and COVID-19
por: Glaus, Matthew J, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_49dtu4fpdcjdmmdf8mck5r17aj